PBH Prestige Consumer Healthcare
$46.44 +1.84%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
+1.84%
YTD
-26.10%
P/E
12.55
P/B
1.49
ROE
9.2%
Div yield
—
Beta
0.03
Market cap
$2.2B
RSI (14)
45
Next earnings
Oct 29, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$45.90
Close
$46.44
VWAP (n/a)
—
Day high
$46.61
Day low
$45.58
Volume
661K
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
PBH vs. NEOG: Which Stock Is the Better Value Option?
Yahoo Finance · Sep 30
Has Prestige Consumer Healthcare (PBH) Fallen Far Enough On Earnings?
Yahoo Finance · Sep 29
Prestige Consumer Healthcare (PBH) Could Be 30% Undervalued After Its 2027 Targets
Yahoo Finance · Sep 29
Prestige Consumer Healthcare Eyes Clear Eyes Recovery, $270M+ Free Cash Flow
Yahoo Finance · Sep 27
PBH or NEOG: Which Is the Better Value Stock Right Now?
Yahoo Finance · Sep 14
Prestige Consumer Healthcare Inc. to Participate in Barclays Global Consumer Conference
Yahoo Finance · Sep 8
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
8-K Aug 14, 2026 View → 10-Q Aug 6, 2026 View → 8-K Aug 6, 2026 View → 8-K Jul 15, 2026 View → 8-K Jul 6, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell PBH. Try it in the Lab to size a position and see the risk.